Skip to main content
DEVA HOLDİNG A.Ş. logo

DEVA HOLDİNG A.Ş. — Investor Relations & Filings

Ticker · DEVA ISIN · TRADEVAW91E2 LEI · 959800K5PD9GB1EHW234 IS Manufacturing
Open in API
Filings indexed 1,636 across all filing types
Latest filing 2023-11-16 Capital/Financing Update
Country ES Spain
Listing IS DEVA

About DEVA HOLDİNG A.Ş.

https://www.deva.com.tr

Established in 1958, DEVA Holding A.Ş. is a pharmaceutical company focused on the development, production, and marketing of medicinal products for human use and active pharmaceutical ingredients (APIs). The company also produces veterinary drugs. DEVA Holding maintains a diverse product portfolio, which includes antineoplastic and immunomodulating agents, and makes its products available on a global scale. Its international business operations are managed through various models, including distributorships, out-licensing, and direct supply agreements.

Recent filings

Filing Released Lang Actions
Nitelikli Yatırımcılara Satılmak Üzere Finansman Bonosu İhracı
Capital/Financing Update Classification · 1% confidence The document details the completion of a sale for a 'Finansman Bonosu' (Financing Bill) issued to qualified investors. It specifies the nominal amount sold (200,000,000 TRY), maturity date (14.11.2024), interest rates, and intermediary details. This is a specific announcement regarding a debt issuance and capital structure activity, not a general report (like 10-K or IR) or a simple announcement of a report (RPA). The most fitting category is 'Capital/Financing Update' (CAP), as it reports on the finalization of a financing instrument sale.
2023-11-16 English
Representation Letter (Consolidated)
Audit Report / Information Classification · 1% confidence The document contains a 'Representation Letter' signed by the Chairman of the Audit Committee and the CFO. It explicitly states that the company's 'not-independently reviewed Consolidated Financial Statements for the period of 1 January 2023-30 September 2023' and the 'Board of Directors' Interim Report' are being presented. The period covered (January 1 to September 30) indicates a nine-month report, which corresponds to an Interim/Quarterly Report (IR). The content is the formal declaration accompanying the financial statements, not the announcement of the report's release (RPA) or the full financial statements themselves (IR). Since this is the formal declaration accompanying the interim financial report, it is most closely associated with the Interim Report category (IR). 9M 2023
2023-11-03 Turkish
September 2023 Activity Report
Regulatory Filings
2023-11-03 Turkish
September 2023 Activity Report
Regulatory Filings
2023-11-03 Turkish
September 2023 Activity Report
Report Publication Announcement Classification · 1% confidence The document text is very short (1356 characters) and explicitly states: "Şirketimizin 01.01.2023 - 30.09.2023 dönemi faaliyet raporu ektedir. / Enclosed is the Activity Report for the period of 01.01.2023 - 30.09.2023." This structure—a brief announcement stating that a full report (in this case, an 'Activity Report' covering a nine-month period) is enclosed or attached—perfectly matches the definition of a Report Publication Announcement (RPA), according to the 'MENU VS MEAL' rule. It is not the comprehensive report itself (which would likely be classified as IR if it were the full financial document).
2023-11-03 English
Financial Report
Regulatory Filings
2023-11-03 Turkish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.